News Medical Life Sciences
An article published in the journal Frontiers in Pharmacology describes the utility of plant-derived compound cannabidiol (CBD) in treating cognitive impairments. Cannabidiol has been found to inhibit edema formation and neuroinflammation in traumatic brain-injured mice by regulating blood-brain barrier permeability. Additional preclinical studies have also found that cannabidiol acts as a serotonin 1A receptor agonist and thereby enhances serotoninergic transmission, leading to potential improvement in depression and anxiety conditions.
See full story at News Medical Life Sciences
Sign up for our newsletter!
Get the latest information and inspirational stories for caregivers, delivered directly to your inbox.